AVEO Pharmaceuticals Inc.

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

Prospect Venture Partners makes investments in biomedical technology and life science private and public companies that have proven management teams, proprietary products and innovative technology or services. They provide financing for incubation, seed, first and second venture rounds and expansion capital financings of later-stage. Initial investments range from $500,000 to $10 million and $10 million to $20 million invested over the life of a company. They will serve as lead investor or as co-lead in a syndicate. They typically takes a seat on the boards of their portfolio companies.

MPM invests in companies located in the US and across the globe. The firm focuses on companies that aim to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and health technology sector. They provide financing for early stage transactions.

Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.